Dabigatran acyl-β-D-glucuronide-d3 (TFA)

Dabigatran acyl-β-D-glucuronide-d3 (TFA)

• UNSPSC Description: Dabigatran acyl-β-D-glucuronide-d3 (TFA) is the deuterium labeled Dabigatran Acyl-β-D-Glucuronide trifluoroacetate[1].
• Target Antigen: Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Others
• Field of Research: Others
• Solubility: 10 mM in DMSO
• Smiles: OC([C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1OC(CCN(C2=CC=CC=N2)C(C3=CC=C(C(N=C4CNC5=CC=C(C=C5)C(N)=N)=C3)N4C([2H])([2H])[2H])=O)=O)=O.CC(C(F)(F)F)=O
• Molecular Weight: 762.70
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported